Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Other financing activities (2021 - 2025)

Updated

Valion Bio's Other financing activities was $172,000 in FY2025.

Analysis

Valion Bio (VBIO) Other financing activities (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Valion Bio 129,792.00 -19.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -240,000.00
Sep 30, 2025 90,000.00
Dec 31, 2024 63,000.00
Sep 30, 2021 415,000.00
Jun 30, 2021 -289,000.00
Mar 31, 2021 -74,000.00
API Access

Valion Bio Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VBIO&period=max&api_key=YOUR_API_KEY